| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/14/2002 | WO2002011769A1 Vascular endothelial growth factor 2 |
| 02/14/2002 | WO2002011743A2 Treatment of prostate cancer |
| 02/14/2002 | WO2001098471A8 Human phosphodiesterases |
| 02/14/2002 | WO2001075073A3 Prostate cell lines and their use |
| 02/14/2002 | WO2001073018A3 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 02/14/2002 | WO2001072838A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/14/2002 | WO2001072120A3 A strategy for maintaining pregnancy |
| 02/14/2002 | WO2001070766A3 Therapeutic anti-cytomegalovirus compounds |
| 02/14/2002 | WO2001064874A3 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/14/2002 | WO2001064247A3 Method of treating cancer with anti-neurotrophin agents |
| 02/14/2002 | WO2001062954A8 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 02/14/2002 | WO2001059120A3 Il-17 like molecules and uses thereof |
| 02/14/2002 | WO2001059093A3 Full-length infectious cdna clones of tick borne flavivirus |
| 02/14/2002 | WO2001059068A3 Artificial bone chips, methods for the production thereof and their use |
| 02/14/2002 | WO2001058951A3 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 02/14/2002 | WO2001058921A3 Methods and compositions for generating angiostatin |
| 02/14/2002 | WO2001058915A3 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 02/14/2002 | WO2001055346A3 System for the internal qualitative and quantitative validation of marker indices |
| 02/14/2002 | WO2001051619A3 Genetically modified fibroblast cell |
| 02/14/2002 | WO2001049833A3 Recombinant pinoresinol/lariciresinol reductase, recombinant dirigent protein, and methods of use |
| 02/14/2002 | WO2001048161A3 Human heparanase-related polypeptide and nucleic acid |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | WO2001038362A3 Production of vaccines |
| 02/14/2002 | WO2001037852A3 Methods of inhibiting atrophy or promoting hypertrophy |
| 02/14/2002 | WO2001036589A3 Human ex vivo immune system |
| 02/14/2002 | WO2001021771A3 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 02/14/2002 | WO2001014418A3 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 02/14/2002 | WO2000068258A3 Compounds exhibiting an antibiotic activity |
| 02/14/2002 | WO2000065062A3 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof |
| 02/14/2002 | WO2000044908A9 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 02/14/2002 | WO2000009552A9 Secreted proteins and polynucleotides encoding them |
| 02/14/2002 | WO1997020938A3 Cells with hybrid receptor and gene construct which can be controlled by said hybrid receptor, and use of said cells in gene therapy |
| 02/14/2002 | US20020019520 CBFBGA09: a human SL15 homolog |
| 02/14/2002 | US20020019519 KIAA0551 polynucleotides and polypeptides use |
| 02/14/2002 | US20020019514 Nucleotide sequences coding fusion protein for use in the detection and treatment of diabetes, autoimmune disease and arthritis |
| 02/14/2002 | US20020019339 Culturing cells on a three-dimensional framework under conditions favorable for cellular growth for a pre-determined time period such that an extracellular matrix is secreted onto the framework creating a coating, killing the cells removing |
| 02/14/2002 | US20020019050 Hybrid microorganism for use in gene therapy |
| 02/14/2002 | US20020019048 Methods for restoring or enhancing T-cell immune surveillance following naturally or artificially induced immunosuppression |
| 02/14/2002 | US20020019047 Aggregations; for use in the treatment of autoimune diseases; for use in immunotherapy |
| 02/14/2002 | US20020019046 Generating preferential aggregations; prepare suspension of stem cells, plate on solid surface, harvest aggregations |
| 02/14/2002 | US20020019037 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 02/14/2002 | US20020019031 Genetically engineered cells for use in the generation of heterologous polypeptides |
| 02/14/2002 | US20020019029 Protein; for use in the treatment of cancer, cardiovascular disorders and nervous system disorders |
| 02/14/2002 | US20020019028 Peptide; for use in the treatment of defects associated with polypeptide transfer |
| 02/14/2002 | US20020019000 Polynucleotides coexpressed with matrix-remodeling genes |
| 02/14/2002 | US20020018990 Reagents and methods useful for detecting diseases of the breast |
| 02/14/2002 | US20020018797 Bone prosthetics |
| 02/14/2002 | US20020018785 Methods for producing polynucleotide libraries in vaccinia virus |
| 02/14/2002 | US20020018775 Complexing; separation; gene therapy |
| 02/14/2002 | US20020018769 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 02/14/2002 | US20020018750 Anticancer agents |
| 02/14/2002 | CA2419062A1 Methods for culturing human lung mast cells and uses thereof |
| 02/14/2002 | CA2419052A1 Potential growth factors from the human tumour cell line ht1080 |
| 02/14/2002 | CA2418952A1 A novel member of the lysyl oxidase gene family |
| 02/14/2002 | CA2418950A1 Soluble zcytor 11 cytokine receptors |
| 02/14/2002 | CA2418936A1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 02/14/2002 | CA2418834A1 Iapl-3 a protein inhibitor of apoptosis proteins |
| 02/14/2002 | CA2418779A1 Schizophrenia related gene and protein |
| 02/14/2002 | CA2418445A1 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | CA2418386A1 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | CA2418381A1 Pancreatic progenitor cells |
| 02/14/2002 | CA2418352A1 Assays for alternative lengthening of telomeres |
| 02/14/2002 | CA2418144A1 Urocortin proteins and uses thereof |
| 02/14/2002 | CA2417982A1 Manipulation of arterial-venous identity |
| 02/14/2002 | CA2417915A1 Her-2/neu fusion proteins |
| 02/14/2002 | CA2417909A1 Isolation and use of solid tumor stem cells |
| 02/14/2002 | CA2417769A1 Drug metabolizing enzymes |
| 02/14/2002 | CA2417767A1 Peptides presented by cells |
| 02/14/2002 | CA2417722A1 Mutant trichoderma reesei egiii cellulases dna encoding such egiii compositions and methods for obtaining same |
| 02/14/2002 | CA2417707A1 Sid.rtm. nucleic acids and polypeptides selected from a pathogenic strain of hepatitis c virus and applications thereof |
| 02/14/2002 | CA2417676A1 Sequences for integrin alpha-8 |
| 02/14/2002 | CA2417595A1 Cryopreservation of sperm |
| 02/14/2002 | CA2417589A1 Motor proteins and methods for their use |
| 02/14/2002 | CA2417587A1 Transporters and ion channels |
| 02/14/2002 | CA2417368A1 Suppressor gene |
| 02/14/2002 | CA2417214A1 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |
| 02/14/2002 | CA2416982A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | CA2416890A1 Therapeutic anti-melanoma compounds |
| 02/14/2002 | CA2416633A1 Enhanced replication of hcv rna |
| 02/14/2002 | CA2386103A1 Vascular endothelial growth factor 2 |
| 02/13/2002 | EP1179592A1 Proteins nectin-3 |
| 02/13/2002 | EP1179591A1 Sodium ion-driven chloride/bicarbonate exchanger |
| 02/13/2002 | EP1179587A1 Method for diminishing specific immune reactions |
| 02/13/2002 | EP1179541A1 Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 02/13/2002 | EP1179539A1 Novel protein having hemolytic activity and gene encoding the protein |
| 02/13/2002 | EP1179350A2 Encapsulated cell system for implantation into the human CNS |
| 02/13/2002 | EP1179187A1 Use of genes of the deoxy-d-xylulose phosphate biosynthetic pathway for altering the concentration of isoprenoid |
| 02/13/2002 | EP1179183A1 A method for identifying pre-neoplastic and/or neoplastic states in mammals |
| 02/13/2002 | EP1179179A1 Use of an antibody to detect basophiles and/or mast cells |
| 02/13/2002 | EP1179176A1 Enriched antigen-specific t-cells, and related therapeutic and prophylactic compositions and methods |
| 02/13/2002 | EP1179094A2 Assay for the detection of paclitaxel resistant cells in human tumors |
| 02/13/2002 | EP1179093A1 Expression of ets-domain proteins in cancer |
| 02/13/2002 | EP1179086A2 Methods of identifying therapeutic compounds in a genetically defined setting |
| 02/13/2002 | EP1179083A1 Triple hybrid amplicon vector systems to generate retroviral packaging lines |
| 02/13/2002 | EP1179082A2 Improved retroviral production by inhibition of the enveloppe cell receptor |
| 02/13/2002 | EP1179078A1 Starch granules containing a recombinant polypeptide of interest, method for obtaining same and uses |
| 02/13/2002 | EP1179075A2 Bacillus circulans xylanase mutants |
| 02/13/2002 | EP1179069A1 GENE ISOLATED FROM $i(RICINUS COMMUNIS) ENCODING A NEW PROTEIN THAT INTERACTS WITH THE OLEATE 12-HYDROXYLASE ENZYME |
| 02/13/2002 | EP1179067A1 Neuroprotective properties of gdf-15, a novel member of the tgf-beta superfamily |
| 02/13/2002 | EP1179066A2 Extracellular signaling molecules |